Previous 10 | Next 10 |
Alamar Biosciences partners with Abcam to drive understanding of the human proteome Alamar selects Abcam as a key provider of antibody content for its propriety NULISA technology platform Canada NewsWire FREMONT, Calif. and CAMBRIDGE, England, Jan....
Penny stocks have become some of the hottest things to buy during this latest leg of the market’s bull run. Despite the pullback in the S&P 500 this week, the slight dip pales in comparison to the year-to-date move so far. This year, for example, the SPY ETF started January a...
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome As an element of Nautilus' overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam's ant...
Abcam completes $340m strategic acquisition and expands kit capacity and capability PR Newswire - Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene , further growing kits and assays portfolio - Supporting the g...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...
CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its interim results for the six- ...
Abcam (NASDAQ:ABCM) inks agreement to acquire BioVision, a wholly owned subsidiary of Boai NKY Medical Holdings Ltd. for $340M on a cash free/debt free basis. The transaction will be funded from existing cash resources and a partial drawdown of Abcam’s Revolving Credit Facility and is ...
Life sciences company Abcam (ABCZF) has inaugurated a new facility in Boston, Massachusetts. The 100,000ft2 facility will serve as a hub for Abcam's R&D and commercial activities in the region as the company approaches 20 years of operation in the U.S. The space more than doubles Abcam's ...
Abcam opens new US facility in Boston, MA Supporting accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforcing commitment to the region as Abcam approaches 20 years of US presence PR Newswire ...
Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The strategy seeks to invest in a small number of industry-leading companies with sustainable competitive advantages and the opportunity to generate durab...
News, Short Squeeze, Breakout and More Instantly...
Danaher Completes Acquisition of Abcam PR Newswire WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.0...
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) ...
2023-11-19 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...